Skip to content

Omega-3 Fatty Acid Dietary Intervention (O3DI)

Omega-3 Fatty Acid Dietary Intervention for Dyslipidemia of Obesity in Children 10 to <18 Years of Age: O3DI Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05025943
Enrollment
19
Registered
2021-08-30
Start date
2021-08-16
Completion date
2023-03-15
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia

Brief summary

Elevated cholesterol, including triglyceride levels, can lead to the development of cardiovascular disease in adulthood. A diet that is rich in omega-3 fatty acids (O3FA) can improve triglyceride levels in a way that is safe and does not require medication. This is a single-center, prospective, unblinded, randomized-controlled dietary intervention study to assess the impact of an omega-3 fatty acid diet compared to a standard lifestyle intervention on serum triglyceride in patients with hypertriglyceridemia. The study consists of an 8-week dietary treatment period followed by an 8-week observation period.

Interventions

OTHERDiet intervention

The intervention group will receive diet counseling and information to implement a standard lifestyle intervention plus omega-3 fatty acid enriched foods Diet assessment and counseling provided throughout study.

OTHERControl group

The control group will receive diet counseling and information to implement a standard lifestyle intervention Diet assessment and counseling provided throughout study.

Sponsors

Nemours Children's Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female patients who are 10 -17 years of age 2. BMI greater than or equal to the 85th percentile 3. Clinical serum triglyceride level \>150 mg/dl and \< 500 mg/dl performed between 3 months and 1 week prior to study visit 1 4. Ability to follow the study procedures and adhere to the diet counseling recommendations 5. Written parental permission and assent are obtained prior to any research procedures

Exclusion criteria

1. Type 2 DM (hemoglobin A1C \>6.6%) 2. Isotretinoin use 3. Chronic kidney disease (CKD) 4. Uncontrolled hypothyroidism 5. Warfarin use 6. Liver disease (NAFLD is allowed) 7. Renal disease 8. Corticosteroid use 9. Omega-3 fatty acid use (prescription or supplement) 10. Allergy to fish and/or nuts 11. Currently pregnant or planning to become pregnant during the course of this trial - confirmed by date of LMP/querying family 12. Any significant medical condition which the investigator believes would interfere with participation in this study

Design outcomes

Primary

MeasureTime frameDescription
change in serum triglyceride level after an 8-week diet intervention compared to baseline8 weeksThe study will test whether omega-3 fatty acid enriched diet is associated with a 20% or greater reduction in serum triglyceride levels.

Secondary

MeasureTime frameDescription
change red blood cell omega-3 fatty acid content / index after an 8-week diet intervention compared to baseline8 weeksTotal levels of omega-3 fatty acids in red blood cell membrane phospholipids are measured. Percentages are reported as an index. The study will identify the index/total omega-3 fatty acid in red blood cells following initiation of an omega-3 fatty acid enriched diet.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026